Lysogenic transfer of mef(A) and tet(O) genes carried by Phim46.1 among group A streptococci.

Antimicrobial Agents and Chemotherapy
Maria Chiara Di LucaL A Vitali

Abstract

We report the ex vivo lysogenic transfer of erythromycin and tetracycline resistance genes among group A streptococci (GAS). Of 42 susceptible strains, 69% acquired erythromycin/tetracycline resistance when infected with purified supernatants from strain m46 culture containing the phage Φm46.1. A significant emm-type-dependent barrier to lysogenic transfer was not observed. The emm12 strains were the only strains susceptible to the lytic action of the bacteriophage preparation.

References

Jan 25, 1968·Biochemical and Biophysical Research Communications·C G LeonardR M Cole
Jul 1, 1966·Journal of Bacteriology·P L Friend, M D Slade
Nov 1, 1996·Antimicrobial Agents and Chemotherapy·J SutcliffeL Wondrack
Mar 8, 2003·Journal of Clinical Microbiology·Claudia ZampaloniSandro Ripa
Mar 18, 2005·The Journal of Antimicrobial Chemotherapy·Michael T HalpernLionel A Mandell
Mar 18, 2005·The Journal of Antimicrobial Chemotherapy·Eleonora GiovanettiPietro E Varaldo
Oct 12, 2005·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·S D'ErcoleL A Vitali
Mar 15, 2006·International Journal of Medical Microbiology : IJMM·Horst MalkeJoseph J Ferretti
Aug 31, 2006·Antimicrobial Agents and Chemotherapy·D Ashley RobinsonDebra E Bessen
Aug 30, 2007·PloS One·Stephen B Beres, James M Musser
Jan 9, 2008·The Journal of Infectious Diseases·Ivo VojtekEmmanuelle Charpentier
Nov 13, 2008·Antimicrobial Agents and Chemotherapy·Pietro E VaraldoEleonora Giovanetti
Mar 13, 2009·Journal of Clinical Microbiology·Luca Agostino VitaliSandro Ripa
Oct 28, 2009·Antimicrobial Agents and Chemotherapy·Andrea BrencianiEleonora Giovanetti

❮ Previous
Next ❯

Citations

Aug 24, 2012·Future Microbiology·Scott T ChanceyDavid S Stephens
Oct 3, 2015·Diagnostic Microbiology and Infectious Disease·Luca Agostino VitaliDezemona Petrelli
May 31, 2015·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·G GherardiL A Vitali
Nov 17, 2015·Japanese Journal of Infectious Diseases·Masakado MatsumotoTadao Hasegawa
May 31, 2019·Reviews in Medical Virology·Rizka O A Jariah, Mohamad S Hakim
Oct 31, 2020·Frontiers in Microbiology·Cinthia Alves-BarrocoPedro Viana Baptista
May 22, 2019·Microbiology Spectrum·W Michael McShanScott V Nguyen

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Bacteriophage: Phage Therapy

Phage therapy uses bacterial viruses (bacteriophages) to treat bacterial infections and is widely being recognized as an alternative to antibiotics. Here is the latest research.